<DOC>
	<DOCNO>NCT00958841</DOCNO>
	<brief_summary>This study ass effectiveness safety pasireotide long-acting release patient rare tumor neuroendocrine origin .</brief_summary>
	<brief_title>Study Pasireotide Patients With Rare Tumors Neuroendocrine Origin</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Pituitary Diseases</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Cardiac Complexes , Premature</mesh_term>
	<mesh_term>Pituitary Neoplasms</mesh_term>
	<mesh_term>Nelson Syndrome</mesh_term>
	<mesh_term>ACTH Syndrome , Ectopic</mesh_term>
	<mesh_term>Cushing Syndrome</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Male Female Patients least 18 year old Patient rare tumor neuroendocrine origin , tumor : 1. pancreas 2. pituitary gland 3 . Nelson syndrome 4. ectopicACTH secrete tumor Patients fail standard care treatment standard care treatment exist Signed Informed Consent Patients active gallbladder disease Patients ongoing plan antineoplastic interferon therapy Poorly control diabetes mellitus Female patient pregnant lactating , childbearing potential practicing medically acceptable method birth control Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Rare tumor neuroendocrine origin</keyword>
	<keyword>NETs pancreatic</keyword>
	<keyword>Pituitary NETs</keyword>
	<keyword>EAS Tumors</keyword>
	<keyword>Nelson 's Syndrome</keyword>
	<keyword>Pancreatic neoplasm</keyword>
	<keyword>pituitary neoplasm</keyword>
	<keyword>Nelson Syndrome</keyword>
	<keyword>ectopic ACTH syndrome</keyword>
	<keyword>pasireotide LAR</keyword>
	<keyword>PNETs</keyword>
	<keyword>PiNETS</keyword>
</DOC>